Health Care: Drugs

Biogen Inc (BIIB: NASDAQ)

$308.17 n/a | n/a%
08/26/16 - 04:00 PM ET
Company Income Statement
Dec 2015 Dec 2014 Dec 2013 Dec 2012
Sales 9.42B 8.51B 5.81B 5.52B
Cost of Sales 1.02B 972.65M 668.93M 382.05M
Gross Operating Profit 8.40B 7.54B 5.14B 5.13B
Selling, General, and Administrative Expenses 2.11B 2.23B 1.80B 1.60B
Research & Development 2.01B 1.89B 1.44B 1.33B
Operating Income before D & A (EBITDA) 4.28B 3.41B 1.90B 2.20B
Depreciation & Amortization 600.40M 688.15M 531.74M 365.65M
Interest Income 22.10M 12.20M 8.20M 29.50M
Other Income - Net 1.28B 1.19B 1.12B 21.33M
Special Income / Charges -30.50M 38.89M 547.00K 0.00
Total Income Before Interest Expenses (EBIT) 4.85B 3.96B 2.50B 1.89B
Interest Expense 95.50M 29.50M 31.90M 36.50M
Pre-Tax Income 4.75B 3.93B 2.46B 1.85B
Income Taxes 1.16B 989.94M 601.01M 470.55M
Minority Interest 46.20M 6.78M 0.00 0.00
Net Income From Continuing Operations 3.59B 2.94B 1.86B 1.38B
Net Income From Discontinued Operations 0.00 0.00 0.00 0.00
Net Income From Total Operations 3.59B 2.94B 1.86B 1.38B
Extraordinary Income/Losses 0.00 0.00 0.00 0.00
Income From Cum. Effect of Acct. Change 0.00 0.00 0.00 0.00
Income From Tax Loss Carryforward 0.00 0.00 0.00 0.00
Other Gains / Losses 0.00 0.00 0.00 0.00
Total Net Income 3.55B 2.93B 1.86B 1.38B
Normalized Income
(Net Income From Continuing Operations,
Ex. Special Income / Charge)
3.72B 2.90B 1.86B 1.38B
Preferred Dividends
Net Income Available To Common 3.59B 2.94B 1.86B 1.38B
Basic EPS from Continuing Ops. 15.37 12.42 7.86 5.80
Basic EPS from Discontinued Ops. 0.00 0.00 0.00 0.00
Basic EPS from Total Operations 15.37 12.42 7.86 5.80
Basic EPS from Extraordinary Inc. 0.00 0.00 0.00 0.00
Basic EPS from Cum Effect of Accounting Change 0.00 0.00 0.00 0.00
Basic EPS from Tax Loss Carryf'd. 0.00 0.00 0.00 0.00
Basic EPS from Other Gains (Losses) 0.01 0.00 0.00 0.00
Basic EPS, Total 15.38 12.42 7.86 5.80
Basic Normalized Net Income/Share 15.91 12.25 7.86 5.81
EPS fr Continuing Ops. 15.34 12.37 7.81 5.76
EPS fr Discontinued Ops 0.00 0.00 0.00 0.00
EPS fr Total Ops. 15.34 12.37 7.81 5.76
EPS fr Extraord. Inc. 0.00 0.00 0.00 0.00
EPS fr Cum Effect of Accounting Change 0.00 0.00 0.00 0.00
EPS fr Tax Loss Carfd. 0.00 0.00 0.00 0.00
EPS fr Other Gains (L) 0.00 0.00 0.00 0.00
EPS, Total 15.34 12.37 7.81 5.76
Diluted Normalized Net Inc/Shr
(Net Income From Continuing Operations,
Ex. Special Income / Charge)
15.87 12.21 7.81 5.77
Dividends Paid per Share 0.00 0.00 0.00 0.00

Portfolios with BIIB

Latest BIIB Headlines from TheStreet

More Financial News for BIIB

Press Releases for BIIB

See All Press Releases
brokerage partners
connect with Stockpickr
Fan us on FaceBook
Follow us on Twitter